Manufacturer of Controlled Substances; Notice of Application, 23948 [E6-6115]

Download as PDF 23948 Federal Register / Vol. 71, No. 79 / Tuesday, April 25, 2006 / Notices Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. By order of the Commission. Issued: April 20, 2006. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–6202 Filed 4–24–06; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Antitrust Division wwhite on PROD1PC65 with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—The Composites Consortium Notice is hereby given that, on March 27, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), The Composites Consortium (‘‘TCC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the consortium and (2) the nature and objectives of the consortium. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the consortium are: Alliant Techsystems, Iuka, MS; Allied Aerospace, Newport News, VA; Bell Helicopter-TEXTRON, Inc., Fort Worth, TX; The Boeing Company, St. Louis, MO; Clemson University, Clemson, SC; Diaphorm Technologies, LLC, Salem, NH; General Dynamics Electric Boat, Groton, CT; Goodrich Corporation, Santa Fe Springs, CA; Graftech International Ltd., Parma, OH; Hitco Carbon Composites, Los Angeles, CA; Maverick Corporation/ Canyon Composites, Blue Ash, OH; Mentis Sciences Inc., Manchester, NH; Mississippi State University, Mississippi State, MS; New Jersey Institute of Technology, Newark, NJ; Northrop Grumman Newport News/ Ship Systems, Newport News, VA; Northrop Grumman Integrated Systems, El Segundo, CA; Pennsylvania State University—Applied Research Laboratory, State College, PA; Raytheon Company, Tucson, AZ; Specialty Materials, Inc., Lowell, MA; TPI Composites, Inc., Warren, RI; Vought Aircraft Industries, Inc., Dallas, TX; and South Carolina Research Authority, North Charleston, SC. The general area VerDate Aug<31>2005 16:59 Apr 24, 2006 Jkt 208001 of TCC’s planned activity is to further the state of the art and practice of employing composites in the manufacture of complex structures, systems, and components thereof. The intent is to: (a) Improve the affordability to the Navy and other Government agencies of structures and systems; (b) increase the technical and manufacturing capability of TCC members; and (c) broadly disseminate the technology. Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 06–3868 Filed 4–24–06; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Notice is hereby given that, on March 30, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et. seq. (‘‘the Act’’), PXI Systems Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Amida Technology, Inc., Taipei, Taiwan has been added as a party to this venture. Also, SMA Regelslysteme GmbH, Niestetal, Germany has withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems Alliance, Inc. intends to file additional written notification disclosing all changes in membership. On November 22, 2000, PXI Systems Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on January 6, 2006. A notice was published in the Federal PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Register pursuant to Section 6(b) of the Act on January 26, 2006 (71 FR 4379). Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 06–3869 Filed 4–24–06; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 20, 2005, August 4, 2005 and September 2, 2005, Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letters to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II: Drug Codeine (9050) ............................. Dihydrocodeine (9120) ................. Methadone (9250) ........................ Alfentanil (9737) ........................... Schedule II II II II The company plans to manufacture in bulk, for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than June 26, 2006. Dated: April 18, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–6115 Filed 4–24–06; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\25APN1.SGM 25APN1

Agencies

[Federal Register Volume 71, Number 79 (Tuesday, April 25, 2006)]
[Notices]
[Page 23948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-6115]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 20, 2005, August 4, 2005 
and September 2, 2005, Cody Laboratories, Inc., 601 Yellowstone Avenue, 
Cody, Wyoming 82414, made application by letters to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed in 
Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Methadone (9250)...........................  II
Alfentanil (9737)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture in bulk, for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than June 26, 2006.

    Dated: April 18, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-6115 Filed 4-24-06; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.